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Spire stimulates nucleation by Cappuccino and 
binds both ends of actin filaments
ABSTRACT The actin nucleators Spire and Cappuccino synergize to promote actin assembly, 
but the mechanism of their synergy is controversial. Together these proteins promote the 
formation of actin meshes, which are conserved structures that regulate the establishment of 
oocyte polarity. Direct interaction between Spire and Cappuccino is required for oogenesis 
and for in vitro synergistic actin assembly. This synergy is proposed to be driven by elonga-
tion and the formation of a ternary complex at filament barbed ends, or by nucleation and 
interaction at filament pointed ends. To mimic the geometry of Spire and Cappuccino in vivo, 
we immobilized Spire on beads and added Cappuccino and actin. Barbed ends, protected by 
Cappuccino, grow away from the beads while pointed ends are retained, as expected for 
nucleation-driven synergy. We found that Spire is sufficient to bind barbed ends and retain 
pointed ends of actin filaments near beads and we identified Spire’s barbed-end binding 
domain. Loss of barbed-end binding increases nucleation by Spire and synergy with Cappuc-
cino in bulk pyrene assays and on beads. Importantly, genetic rescue by the loss-of-function 
mutant indicates that barbed-end binding is not necessary for oogenesis. Thus, increased 
nucleation is a critical element of synergy both in vitro and in vivo.
INTRODUCTION
Cells contain varied actin-based structures that fulfill distinct func-
tional roles. The actin cytoskeleton is malleable due to dynamic 
structural regulation by a range of distinct actin-binding proteins. 
The first step to building a structure is generally catalysis of new 
actin filaments, so-called nucleation. Both a kinetic barrier and 
certain actin-binding proteins, such as profilin, prevent spontaneous 
nucleation in the cell. Instead, actin nucleators stimulate this process 
in highly regulated manners. There are three known classes of actin 
nucleators that function by distinct mechanisms: the Arp2/3 com-
plex, formins, and tandem-WH2 domain nucleators. A developing 
trend is that none of these proteins works independently. Effector 
proteins can inhibit or enhance the activity of actin nucleators. 
Usually, the effector is not a nucleator. In some cases, two indepen-
dent nucleators also work together. A poorly understood example 
of such interplay is the collaboration between Cappuccino (Capu, a 
formin) and Spire (Spir, a tandem-WH2 nucleator).
Both Spir and Capu are required for oogenesis. This discovery 
was first made in Drosophila and subsequently demonstrated in 
mice (Manseau and Schupbach, 1989; Leader et al., 2002; Pfender 
et al., 2011). In both cases, Capu (or Fmn-2, one of two mammalian 
homologues) and Spir (or mSpire, referring to mammalian homo-
logues, Spire-1 and Spire-2) build a mesh of actin that fills the 
oocyte (Dahlgaard et al., 2007; Azoury et al., 2008; Schuh and 
Ellenberg, 2008; Pfender et al., 2011). The discovery that both Spir 
and Capu are actin nucleators led to the question of why two nuclea-
tors would be needed to build one structure (Quinlan et al., 2005). 
We now know that direct interaction between Spir and Capu is 
required for their function (Quinlan, 2013). Detailed biochemical 
analyses and structural biology provide insight into the interaction: 
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FIGURE 1: Domain architecture and bead methodology. (A) Domain architecture of Drosophila melanogaster 
Cappuccino (Capu), Spire (Spir), and truncations used. CID, Capu inhibitory domain (orange); FH1/FH2, formin 
homology domains (1, dark blue; 2, red); T, tail (yellow); KIND, kinase noncatalytic C-lobe domain (purple); WH2, 
Wiskott-Aldrich syndrome homology domains (light blue); mFYVE, modified FYVE (zinc finger) domain (green). Spir has 
four WH2 domains, named WH2-A through WH2-D. The sequence of WH2-A and mutations that disrupt its actin 
binding are shown. (B) Bead experiment methodology. To decorate streptavidin-coated microspheres (gold) with 
SpirNT, and to bind the microspheres to the coverslip, biotin (green) is conjugated both to coverslips and to SpirNT. 
Two potential orientations of the actin filament distinguish Spir’s primary activities at each end: capping filaments at 
their barbed ends (left) and nucleating filaments from their pointed ends (right).
the N-terminal Spir-KIND domain binds the C-terminal Capu-tail with 
∼100 nM affinity (Figure 1; Quinlan et al., 2007; Pechlivanis et al., 
2009; Vizcarra et al., 2011; Zeth et al., 2011). However, our under-
standing of the functional consequences of the interaction remains 
incomplete. Capu, like all formins, is a dimer. It can bind two copies 
of Spir and, thereby, accelerate actin assembly by Spir (Quinlan et al., 
2007; Vizcarra et al., 2011). In contrast, Spir’s KIND domain inhibits 
nucleation by Capu and competes with barbed ends for Capu bind-
ing, effectively inhibiting Capu’s ability to accelerate actin assembly 
(Quinlan et al., 2007; Vizcarra et al., 2011). However, when a human 
Spire-1 construct, containing both the KIND domain and four tan-
dem WH2 domains, is mixed with the C-terminal half of Fmn-2, actin 
assembly is greatly enhanced (Montaville et al., 2014). So-called 
ping-ponging—Spir and Fmn-2 alternately binding to the barbed 
end of filaments—is observed and was proposed to account for syn-
ergistic actin assembly (Montaville et al., 2014).
Spir is enriched at the cortex of the Drosophila oocyte and local-
izes to Rab11-positive vesicles in mouse oocytes, and the C-termi-
nal mFYVE domain of mSpire-1 binds phospholipids (Quinlan et al., 
2007; Pfender et al., 2011; Quinlan, 2013; Tittel et al., 2015). While 
Fmn-2 is also observed on Rab11-positive vesicles in mouse oo-
cytes, GFP-Capu appears diffuse throughout the Drosophila oocyte 
(Dahlgaard et al., 2007; Schuh, 2011; Quinlan, 2013). In the mouse 
oocyte, Rab11-positive vesicles that contain mSpire, Fmn-2, and 
myosin V are at nodes of the actin mesh that fills the oocyte (Schuh, 
2011). Mesh dynamics contribute to nucleus positioning and long 
distance transport of the Rab11-positive vesicles toward the cell 
cortex (Holubcová et al., 2013; Almonacid et al., 2015; Ahmed 
et al., 2018). A model to account for the long distance transport 
includes mSpire/Fmn-2–nucleated actin filaments growing with their 
barbed ends remaining near the vesicles, creating tracks that 
myosin V on neighboring vesicles can walk along, pulling vesicles 
together (Schuh, 2011). When ping-ponging was observed in vitro, 
Montaville et al. (2014) expanded on this model, proposing that 
barbed ends of filaments and/or prenuclei are recruited by vesicle-
bound mSpire and handed off to Fmn-2 to stimulate elongation.
To learn more about how Spir and Capu interact to build 
actin filaments and structures, we combined biochemistry and fly 
genetics. We developed a bead-based assay, in which we attached 
the N-terminal half of Spir (SpirNT) to beads and added the 
unconjugated C-terminal half of Capu (CapuCT), based on reported 
localization data (see Figure 1A for construct definitions). Through 
this work we found that beads decorated with SpirNT and CapuCT 
(CapuCT/SpirNT-beads) nucleate filaments that grow with their 
barbed ends away from beads, protected by CapuCT, opposite to 
the polarity expected based on the ping-pong model. We found that 
SpirNT alone on beads (SpirNT-beads) nucleates filaments oriented 
the same way. We also found that SpirNT-beads retain the pointed 
ends of filaments at the bead with a dwell time of ∼100 s while neigh-
boring SpirNT-beads capture and cap the barbed ends of filaments 
for several hundreds of seconds. Next, we identified the domain nec-
essary for Spir’s high-affinity barbed-end binding. Surprisingly, 
barbed-end binding is not necessary for oogenesis and loss of 
barbed-end binding increases Spir/Capu synergy in vitro. These ge-
netic and biochemical data indicate that ping-ponging at the barbed 
end is neither the dominant source of synergy nor necessary in vivo. 
Instead, enhanced nucleation by the Spir/Capu complex is critical.
RESULTS
Barbed ends project away from CapuCT/SpirNT-beads
To learn more about how Spir and Capu interact to build actin 
filaments and structures, we developed a bead-based assay. Spir is 
enriched at the cortex of the Drosophila oocyte, localizes to Rab11-
positive vesicles in mouse oocytes, and the C-terminal mSpire-
mFYVE domain binds phospholipids (Quinlan et al., 2007; Quinlan, 
2013; Pfender et al., 2011; Tittel et al., 2015). While Fmn2 is also 
observed on vesicles in the mouse oocyte, GFP-Capu appears 
diffuse throughout the Drosophila oocyte (Schuh, 2011; Quinlan, 
2013). On the basis of these data, we immobilized SpirNT on beads 
and added unconjugated CapuCT. To do so, we biotinylated a C-
terminal Avitag on SpirNT and mixed it with CapuCT. We then 
attached these complexes to streptavidin-coated beads under 
Volume 31 February 15, 2020 Nucleation drives Spir/Capu synergy | 275 
saturating conditions (Figure 1B). We introduced the decorated 
beads to a sparsely biotinylated flow chamber to visualize them with 
total internal reflection fluorescence (TIRF) microscopy. Any unbound 
SpirNT or CapuCT was washed away. When we added actin (20% 
OG-actin) and profilin to the flow chamber, extensive and rapid 
polymerization followed (Figure 2A and Supplemental Video 1).
Two groups proposed that Spir/Capu-coated vesicles have fila-
ments with barbed ends apposed to the vesicle and pointed ends 
growing away (Figure 1B; Schuh, 2011; Montaville et al., 2014). We 
tested this model by examining the orientation of filaments growing 
off of CapuCT/SpirNT-beads. By lowering the concentration of actin 
(600 nM), we decreased nucleation such that we could track indi-
vidual filaments. Under these conditions, we observed filaments 
growing from but “retained” at the beads (Supplemental Video 2). 
We carefully analyzed nine individual filaments. In every case, 
fiducial marks that do not move with respect to the bead, and 
increased fluorescence intensity at filament ends (i.e., ends brighter 
due to the addition of unbleached monomers [Kovar and Pollard, 
2004]), away from the bead, indicated that barbed ends grow away 
from the bead surface (Figure 2B). Filaments growing under 
these conditions elongated away from the bead at a rate of 50 ± 
16 s−1 μM−1 (mean ± SD, n = 11), consistent with Capu-mediated 
elongation. We expected to see the opposite orientation of fila-
ments with Capu directly conjugated to the beads. For unknown 
reasons, Capu was not functional when attached to beads through 
a number of different linkers. Instead, we conjugated the formin 
mDia1 to beads. In this case, fiducial marks were displaced at the 
rate of filament elongation (∼17 s−1 μM−1) and the addition of 
FIGURE 2: Barbed ends project away from CapuCT/SpirNT-beads. (A) Actin assembles off of CapuCT/SpirNT-beads. 
See also Supplemental Video 1. (B) A single filament is nucleated and retained by a bead. Kymograph (bottom) shows 
fiducial marks, such as bleached filament regions, which do not move with respect to the bead (cyan triangles). New, 
labeled actin is added away from the bead, indicating growth away from the bead. See Supplemental Video 2 for 
another example of retention by CapuCT/SpirNT-beads. (C) A single filament is nucleated and elongated by a bead 
coated with mDia1. Fiducial marks (highlighted with cyan triangles) in the kymograph are displaced from the bead at the 
rate of elongation, indicating growth at the bead. See also Supplemental Video 3.
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unbleached monomers was no longer observed at the filament end 
away from the bead (Figure 2C and Supplemental Video 3), consis-
tent with barbed-end growth at the bead surface. Together these 
data demonstrate that CapuCT/SpirNT-beads nucleate filaments 
with barbed ends growing away from the bead and suggest that 
CapuCT separates from SpirNT to elongate the filament.
Spir-beads retain the pointed ends of nucleated 
actin filaments
A dense collection of filaments emanated radially from CapuCT/
SpirNT-beads. Because we concluded that CapuCT-mediated 
elongation proceeded away from the beads, the density of actin 
near the bead surface suggested that the pointed ends of filaments 
could be retained by Spir. We repeated the experiments with 
SpirNT-beads, without added CapuCT or profilin, and observed 
similar patterns (Figure 3A and Supplemental Video 4). We 
found that nucleation by SpirNT-beads was suppressed enough to 
observe individual filaments by adding profilin (Figure 3B). We again 
observed filaments retained at and growing away from the bead 
surface (Figure 3C and Supplemental Video 5). Filaments growing 
away from SpirNT-beads elongated at a rate of 16.0 ± 0.3 s−1 μM−1 
(mean ± SD, n = 12), as expected for free barbed ends. The 
filaments near the beads were released over time, demonstrating 
that they were not attached to the surface. The distribution of 
filament dwell times was well fit by a single exponential with an off 
rate of 0.007 ± 0.003 s−1 (n = 70; Figure 3D). We note that retention 
FIGURE 3: SpirNT-beads retain the pointed ends of nucleated actin filaments. (A) SpirNT-beads, in the absence of Capu 
and profilin, also potently polymerize actin. The highlighted region (gold) is magnified and pseudocolored (right) to 
emphasize the enrichment of actin filaments between beads. See also Supplemental Video 4. (B) Nucleation by 
SpirNT-beads is suppressed by profilin. When added at 1 μM (gold box), profilin permits the observation of several, 
individual filaments per bead. (C) SpirNT-beads also retain nucleated filaments. G, growth; B, bead. Fiducial marks (e.g., 
cyan triangle) in the kymograph are not displaced as the filament elongates, indicating growth away from the bead. See 
also Supplemental Video 5. (D) Dwell times of filament pointed ends on beads. Nucleated and retained filaments were 
tracked from SpirNT-beads in the presence of 1 μM actin and 1 μM profilin. All bead-associated filaments were counted 
unless obviously captured from solution or >1 μm in length when first visible. The data are well fit by a single 
exponential (koff = 0.007 ± 0.003 s−1, n = 70 filaments; four independent experiments).
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of filaments by SpirNT-beads was independent of profilin (Supple-
mental Figure S1G and Supplemental Video 6). Furthermore, 
neither filament end was observed to interact with beads coated 
with Spir-KIND and CapuCT (Supplemental Figure S1F), indicating 
that retention is specifically mediated by Spir-WH2 domains.
We did not assume that filaments were oriented with their barbed 
ends out when nucleated by SpirNT-beads because Spir has been 
reported to bind both the barbed and pointed ends of filaments 
(Quinlan et al., 2005; Bosch et al., 2007; Ito et al., 2011). mSpire1 
caps barbed ends with high affinity and SpirNT binds pointed ends 
weakly (nM vs μM Kd’s; Quinlan et al., 2005; Bosch et al., 2007; 
Montaville et al., 2014). We closely analyzed 10 of the 70 filaments 
included in the retention data set. All 10 filaments, growing from 
SpirNT-beads, displayed fiducial marks that did not move with 
respect to the bead and typically had brighter filament ends away 
from the beads, consistent with barbed ends being oriented away 
from the beads (Figure 3C). Thus, we conclude that barbed ends 
grow away from SpirNT-beads and that SpirNT is sufficient to retain 
the pointed ends of actin filaments near beads for >100 s.
SpirNT-beads capture and cap the barbed ends of actin 
filaments
When we examined the dense actin networks emanating from 
beads, we also observed apparent connections between neighbor-
ing beads (Figure 3A). This pattern suggested to us that the barbed 
ends of actin filaments could also be associated with beads. Under 
conditions where individual filaments could be tracked, we ob-
served the “capture” of filaments (Figure 4). The association of cap-
tured filaments with Spir-beads often outlasted the single-filament 
imaging window (10+ min), precluding measurement of an off rate 
and suggesting that the interaction is distinct from retention.
In addition to seeing filaments spanning two beads, we often ob-
served capture of free filaments. We probed the orientation of cap-
tured filaments using two colors of actin. We initiated elongation in 
the presence of Cy3B-actin and stabilized these filaments with 
phalloidin after several minutes. Adding a limiting pool of OG-actin 
(600 nM) plus profilin to favor barbed-end growth, we observed 
that, whether the filament had both ends free (as shown) or one 
end retained by a bead, only the barbed ends of filaments were 
captured by beads (Figure 4A and Supplemental Video 7). Filaments 
captured by beads did not grow measurably, suggesting that they are 
capped at their barbed ends (Figure 4A). Consistent with this conclu-
sion, the fluorescence intensity of the filament near the bead steadily 
declined after binding (Figure 4B). Occasionally, we observed the re-
lease of a barbed end, following capture. In these cases, the filament 
resumed elongation at the same rate as before capture (Figure 4A). 
As noted above, barbed ends do not interact with CapuCT/Spir-
KIND-beads (Supplemental Figure S1F). These data indicate that the 
barbed ends are capped by Spir-WH2 domains, as opposed to being 
nonspecifically stuck to the beads or KIND domain.
FIGURE 4: SpirNT-beads capture and cap the barbed ends of actin filaments. (A) Nucleated filaments (green) grow only 
at their barbed ends (magenta). A free filament (dashed outline) diffuses and grows until it is captured by a SpirNT-bead 
(solid triangle). The filament resumes growth once released by the bead (open triangle). The kymograph shows that the 
growing, barbed end (magenta) is captured/capped by Spir and resumes growth after release. See also Supplemental 
Video 7. (B) Intensity of filament ends decrease after bead capture. Images of a filament immediately before attachment 
and 2 min later. The intensity of the first 1 μm of this filament is plotted vs. time, with 0 s set to the capture event. 
(C) Two filaments (cyan triangles) nucleated by a SpirNT/CapuCT-bead (A) are retained for more than 5 min. Their 
barbed ends are captured (gold triangles) by other CapuCT/SpirNT-beads (B and C). Accelerated growth of these 
filaments (∼50 subunits/s*μM) in the presence of profilin and capping protein indicates that CapuCT is elongating and 
protecting their barbed ends. Filaments did not measurably grow, following capture, suggesting that CapuCT is 
displaced and that the barbed end is bound by SpirNT upon capture. See also Supplemental Video 8.
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To further study the phenomenon of filament capture, we added 
capping protein and CapuCT to the experiment. Under these condi-
tions we observed sustained and accelerated growth (51 ± 
11 s−1 μM−1, mean ± SD, n = 3) of retained filaments or absence of 
growth (n = 2), confirming that CapuCT can separate from SpirNT 
and protect growing filament barbed ends from capping protein 
(Figure 4C). Growing filaments were still captured by beads, sug-
gesting that SpirNT displaces CapuCT from the barbed end (Figure 
4C and Supplemental Video 8). Together these data demonstrate 
that, with or without CapuCT present, Spir-beads can nucleate and 
retain the pointed ends of actin filaments, while neighboring beads 
can capture and cap their barbed ends.
Spir’s WH2-A binds filament barbed ends and reduces 
actin nucleation
Each of Spir’s four WH2 domains contributes differently to nucle-
ation and they bind actin monomers with a range of affinities (from 
∼100 nM to 1.1 μM; Quinlan et al., 2005; Rasson et al., 2015). We 
reasoned that the N-terminal-most WH2 domain, WH2-A, binds 
barbed ends of filaments, based on our earlier observation that 
isolated WH2-A is the only Spir-WH2 domain that slows filament 
growth (Rasson et al., 2015). To test the contribution of WH2-A to 
barbed-end binding, we first established that wild-type SpirNT 
caps barbed ends in a seeded elongation assay, as has been 
shown for mSpire-1 (Bosch et al., 2007). In the presence of actin 
seeds, monomers, and profilin, SpirNT potently inhibited elonga-
tion (Figure 5A). The dose dependence of inhibition indicates an 
apparent affinity of SpirNT for barbed ends of 20 ± 3 nM, similar to 
that reported for mSpire-1 (Figure 5B). We then mutated three 
conserved, hydrophobic residues in WH2-A of SpirNT (SpirNT(A*); 
Figure 1A) to remove actin monomer binding by this domain 
alone. These mutations were previously shown to dramatically de-
crease, if not abolish, actin monomer binding (Quinlan et al., 
2005). When added to the seeded elongation assay, SpirNT(A*) 
was essentially unable to inhibit elongation (Figure 5, A and B). 
Thus, a functional WH2-A domain is necessary for high-affinity, 
barbed-end capping.
In standard pyrene-actin assays, we found that SpirNT(A*) 
assembled actin more potently than wild-type SpirNT (Figure 5C and 
Supplemental Figure S1C). The plateau was consistently lower for 
wild type, suggesting that barbed-end binding by SpirNT is sufficient 
to change the critical concentration under these conditions. We also 
noted that the plateau of SpirNT(A*) pyrene traces did not decrease 
at high concentrations as is seen for wild-type SpirNT, suggesting 
that this mutant does not potently sequester actin monomers (Figure 
5C; Quinlan et al., 2005). We next attached biotinylated SpirNT(A*) 
to beads and added actin and profilin. Consistent with increased 
activity in pyrene assays, we observed faster accumulation of 
filaments from SpirNT(A*)-beads compared with wild-type SpirNT-
beads (Figure 5D and Supplemental Video 9). To compare nucle-
ation rates on beads, we measured the integrated intensity of actin 
within a band 1.6 μm away from the beads. At this proximity, we are 
minimally sensitive to filament elongation and interpret the intensity 
as proportional to the number of filaments; that is, nucleation. We 
measured time courses and calculated the rates of increase in 
OG-actin signal. The difference in rates indicates that nucleation by 
SpirNT(A*) is approximately three times stronger than wild-type 
SpirNT in the presence of profilin (Figure 6, D and E). We also mea-
sured the dwell times of filaments retained by SpirNT(A*)-beads. The 
off rate was not significantly different than that of wild type (koff(WT) = 
0.007 ± 0.003 s−1, koff(A*) = 0.011 ± 0.003 s−1, Student’s t test, p = 0.98; 
Figure 5E), indicating that WH2-A does not play an important role in 
filament retention. Notably, we rarely observed capture events by 
SpirNT(A*)-beads. In several cases, filaments appeared to be close 
enough to a neighboring bead for capture for tens of seconds, but 
sustained association of the barbed end with beads was rare. Taken 
together, these data are consistent with the requirement of func-
tional WH2-A for high-affinity barbed-end binding and demonstrate 
that this domain is not critical for pointed-end binding.
Synergy between Spir and Capu does not require 
barbed-end binding
Previously, synergistic actin assembly by mSpire-1 and Fmn-2 was 
described: the rate of actin assembly by mSpire-1 + Fmn-2 is 
greater than the sum of assembly rates of the individual nuclea-
tors (Montaville et al., 2014). We confirmed that SpirNT and 
CapuCT exhibit a similar synergistic effect in pyrene-actin assem-
bly assays (Figure 6A and Supplemental Figure S1D). In the 
presence of profilin, the assembly rate of SpirNT + CapuCT 
(based on the t1/2 at ≥40 nM SpirNT) was 6× and 15× faster than 
CapuCT or SpirNT, respectively (Figure 6B). As seen for the 
mammalian paralogues, direct interaction was required for 
synergy: SpirNT(Y232K), a mutant that does not bind Capu, does 
not synergize with CapuCT (Supplemental Figure S1E; Vizcarra 
et al., 2011; Montaville et al., 2014).
Montaville et al. (2014) concluded that actin assembly was en-
hanced by mSpire-1 and Fmn-2 alternately binding the barbed end, 
which they dubbed the ping-pong mechanism. Given that 
SpirNT(A*) does not bind to or capture barbed ends, we assume 
that ping-ponging is not possible with this mutant. However, when 
we tested SpirNT(A*) in the pyrene synergy assay, we found approxi-
mately three times enhanced synergy (based on the t1/2 at ≥40 nM 
SpirNT), as opposed to loss of activity (Figure 6, A and B, and Sup-
plemental Figure S1D). The dose dependence of synergy is indistin-
guishable for SpirNT and SpirNT(A*) (Figure 6B). We speculate that 
dose dependence is a function of Spir-KIND/Capu-tail binding, 
which should not be affected in SpirNT(A*). These data lead us to 
propose that enhanced nucleation, not just elongation, drives 
synergy when SpirNT and CapuCT interact.
To directly test whether nucleation is increased by SpirNT and 
CapuCT collaborating, we returned to the bead assay. When 
CapuCT/SpirNT-beads were mixed with actin and profilin, we 
observed potent nucleation (Figure 6C). Consistent with nucleation 
being a significant element of Spir/Capu synergy, the rate of fila-
ment formation was 6.5× greater than in the absence of Capu 
(Figure 6, C–E). Nucleation of profilin–actin by CapuCT/SpirNT(A*)-
beads was even stronger than wild type (4×) and the synergy more 
pronounced (9.5× vs. SpirNT(A*)-beads in the absence of Capu) 
with the actin signal saturating at the measured 1.6 μm radius within 
∼2 min (Figure 6, C and D). Thus, nucleation is potently enhanced 
when SpirNT and CapuCT are combined and loss of barbed-end 
binding by SpirNT leads to even stronger nucleation in the presence 
and absence of CapuCT. These data indicate that enhanced nucle-
ation is a major source of synergy in vitro.
Barbed-end binding is not necessary for oogenesis
Finally, we asked whether barbed-end binding is necessary for 
Drosophila oogenesis. To do so, we used full-length Spir (CG10076, 
splice variant “PB”) with a C-terminal monomeric enhanced green 
fluorescent protein (GFP) tag in a genetic rescue assay. We mutated 
three conserved residues of WH2-A as done in vitro. We previously 
demonstrated that expression of wild-type Spir-GFP, driven by 
germline-specific nanos-Gal4-vp16, is sufficient to rescue fertility in 
flies that lack endogenous Spir (Table 1; Quinlan, 2013). We found 
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that fertility was largely rescued when Spir(A*)-GFP was expressed 
(hatch rate 40% compared with 59% for wild type; Table 1). Consis-
tently, the mesh was present in 11 of 20 oocytes and streaming 
was properly regulated in about half of the oocytes observed 
(Figure 7, D and D′). Thus, barbed-end binding is not necessary 
for mesh formation or oogenesis, though the fertility decrease, 
relative to wild-type rescue, suggests that it may contribute under 
normal conditions.
FIGURE 5: Spir’s WH2-A binds filament barbed ends and reduces actin nucleation. (A) Seeded elongation is inhibited 
by the addition of 12.5–200 nM SpirNT (shades of blue). The addition of 200 nM SpirNT(A*) has no effect (purple). 
(B) Dose-dependent elongation rates are plotted for three experiments. The data are fit with a quadratic equation, 
indicating that SpirNT binds the barbed end with a Kd of 20 ± 3 nM. The line is a fit to all data points, and the Kd is the 
average of three independent experiments. Inhibition by SpirNT(A*) is negligible. (C) SpirNT(A*) assembles actin more 
potently than wild-type SpirNT in a pyrene–actin assembly assay. Plateaus that are independent of Spire concentration 
suggest that SpirNT(A*) does not sequester actin like SpirNT (compare solid lines). (D) SpirNT(A*)-beads nucleate more 
potently than wild type. See also Supplemental Video 9. (E) Quantification of filament pointed-end dwell times on beads 
(koff = 0.011 ± 0.003 s−1, n = 33 filaments; three independent experiments). The off rate is not significantly different from 
wild type (data from Figure 3D).
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FIGURE 6: Synergy between Spir and Capu does not require barbed-end binding. (A) Actin assembly assays in the 
presence of profilin and capping protein. CapuCT alone and SpirNT alone (solid and dashed gray lines) are weak under 
these conditions, but synergize in assembly when combined (blue). SpirNT(A*) synergizes more potently with CapuCT 
(magenta). (B) Dose dependence of t1/2. Solid circles are SpirNT or CapuCT alone (blue and green, respectively; one 
representative experiment shown for each). Open circles indicate the addition of both proteins. SpirNT, blue; 
SpirNT(A*), magenta (n = 3 independent experiments, each); SpirNT(A*B*C*D*), orange (one representative experiment 
shown at each concentration). Raw data are shown in Supplemental Figure S1, A–D. (C) Nucleation is stronger on 
CapuCT/SpirNT(A*)-beads than CapuCT/SpirNT-beads. (D) Quantification of experiments like those shown in C and 
Figure 5D. Fluorescence around beads is expressed as an average percentage of initial values over time (n ≥ 4 beads, 
n ≥ 2 independent experiments per condition). See Materials and Methods for the description of data transformation. 
Data plotted were obtained using 1-μm-diameter beads, 1 μM actin, and 1 μM profilin, with or without CapuCT (solid or 
dashed lines, respectively). S, SpirNT-beads; P, profilin; C, CapuCT. SpirNT-bead data are plotted in blue and SpirNT(A*)-
bead data in magenta. (E) Rates of fluorescence increase, from D. Mean ± SEM are indicated for each condition. The 
initial 50 s of images (t = ∼30–80 s) were used to determine rates. A Student’s t test was performed on each pair of 
conditions indicated (black brackets). ***, p < 0.0001. The difference in activity by SpirNT(A*/WT)-beads (without Capu) 
was not statistically significant (unequal variance; p = 0.13).
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Transgene  
(spir1/Df(2L)Exel6046)a % Hatchedb
Number 
countedb
Spir-GFPc 59 606
Spir(A*B*C*D*)-GFP <2 431
Spir(A*)-GFP 40 619
aGenetic background is in parentheses.
b% hatched is reported as the average of at least three independent trials. 
% hatched is measured 24 h after egg lay. ∼95% w1118 hatch; 0% spir1/Df(2L)
Exel6046 hatch. Number counted is the sum of eggs counted from all trials.
cQuinlan (2013).
TABLE 1: Fertility assays.
FIGURE 7: WH2 domains are necessary for oogenesis. (A) Cartoon of a stage 9 egg chamber. P, posterior. (B–D) Stage 
9 egg chambers dissected from flies with a spir null background, expressing Spir-GFP (B), Spir(A*B*C*D*)-GFP (C), or 
Spir(A*)-GFP (D, D′). Egg chambers were stained with fluorescently labeled phalloidin to detect the presence or absence 
of mesh (left images) and SD projections of autofluorescent yolk granule positions over 2 min (right images) show the 
extent of ooplasmic streaming. Expression of Spir(A*)-GFP results in a mixture of failed (D) and successful rescues 
(11/20 = 55% of stage 9 oocytes had a visible mesh; D′).
WH2 domains are necessary for Drosophila oogenesis
The Spir-KIND domain inhibits CapuCT in pyrene-actin assays 
(Quinlan et al., 2007; Vizcarra et al., 2011). However, genetics 
indicate that Spir and Capu both play positive roles in oocyte 
mesh formation (Manseau and Schupbach, 1989; Dahlgaard 
et al., 2007; Quinlan, 2013). Further, the N-terminal half of Spir 
(containing only the KIND domain and WH2s) is sufficient to 
build the mesh (Dahlgaard et al., 2007; Quinlan, 2013). Com-
bined, these data suggest that Spir’s WH2 domains contribute to 
in vivo function. We decided to test this hypothesis directly, in 
part because Spir(A*)-GFP rescues. In each of Spir’s four WH2 
domains, we mutated three conserved, hydrophobic residues 
that contact actin (Figure 1A). These mutations were previously 
shown to dramatically decrease, if not abolish, actin monomer 
binding (Quinlan et al., 2005). In vitro, SpirNT with all of these 
mutations (SpirNT(A*B*C*D*)) does not accelerate actin assem-
bly (Supplemental Figure S1A; Quinlan et al., 2005). nanos-Gal4-
vp16–driven expression of Spir(A*B*C*D*)-GFP failed to rescue 
fertility (hatch rate <2%; Table 1). In oocytes expressing 
Spir(A*B*C*D*)-GFP, the actin mesh was absent and streaming 
was premature, consistent with loss of actin assembly activity and 
loss of fertility (Figure 7, A–C). Thus, we conclude that actin bind-
ing by at least one of Spir’s WH2 domains is necessary for actin 
assembly and oogenesis.
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DISCUSSION
Spir binds both ends of actin filaments
The bead assay facilitated observation of several steps in actin 
assembly by Spir and Capu. We found that filaments nucleated 
on CapuCT/SpirNT-beads grow with their barbed ends away from 
the bead with enhanced rates, accelerated by CapuCT. Thus, 
SpirNT and CapuCT separate after nucleation, consistent with ge-
netics results (Quinlan, 2013). We also found that CapuCT-bound 
barbed ends would subsequently stop growing if they encoun-
tered CapuCT/SpirNT-beads, suggesting that the barbed end 
was passed from CapuCT to SpirNT. To our surprise, we found 
that SpirNT-beads were sufficient to bind both ends of actin fila-
ments. There are conflicting reports regarding filament-end bind-
ing for two classes of tandem-WH2 nucleators: Spir and VopF/L 
(Liverman et al., 2007; Yu et al., 2011; Pernier et al., 2013, 2016; 
Burke et al., 2017). The N-termini of WH2 domains bind actin 
monomers between subdomains 1 and 3 of actin—the surface 
exposed at the barbed ends of filaments (Hertzog et al., 2004; 
Chereau et al., 2005). It was, therefore, reasonable to expect tan-
dem-WH2 nucleators to associate with filament barbed ends and 
surprising when both VopL and Spir were reported to bind fila-
ment pointed ends (Quinlan et al., 2005; Namgoong et al., 2011; 
Yu et al., 2011). Spir nucleates filaments with free barbed ends 
and inhibits depolymerization of gelsolin-capped filaments, albeit 
weakly (Quinlan et al., 2005). Spir also caps barbed ends of grow-
ing filaments but with nanomolar affinity (Bosch et al., 2007; 
Montaville et al., 2014). Here we present evidence that these ap-
parently conflicting data are all correct. This is not unprecedented. 
Namgoong et al. (2011) and Burke et al. (2017) reported that 
VopL/F can interact with both ends of actin filaments, depending 
on the conditions.
Earlier, we did not observe barbed-end binding by Spir when 
assayed by inhibition of depolymerization (Quinlan et al., 2005). We 
now report high-affinity barbed-end binding in inhibition of elonga-
tion assays. Possibly, Spir binds barbed ends only in the presence of 
actin monomers as was described for N-Wasp (Co et al., 2007). This 
contrasts with VopL/F that primarily bind barbed ends of preformed 
filaments in the absence of free monomer (Burke et al., 2017). The 
first of Spir’s tandem WH2 domains, WH2-A, is necessary to cap 
barbed ends. It is curious that removing function of this WH2 do-
main increases the activity of SpirNT. In earlier work, we did not 
observe a significant difference in actin assembly, with or without 
WH2-A (Quinlan et al., 2005). The original data were acquired with 
higher concentrations of both SpirNT and actin, which may have 
masked the difference. In addition, the data were acquired with a 
slightly longer construct: 1–520 versus 1–490. One possible expla-
nation for enhanced actin nucleation by SpirNT(A*) is that loss of 
capping leads to fewer so-called SA4 complexes (Spir bound to four 
actin monomers). We and others observed SA4 complexes when 
Spir is mixed with actin under polymerizing conditions (Quinlan 
et al., 2005; Bosch et al., 2007). We originally interpreted these 
structures as prenuclei. In contrast, Bosch et al. (2007) proposed that 
they are stable structures that sequester actin monomers. Whether 
there are two paths (i.e., nucleation vs. SA4 complex), or one (nucle-
ation, with formation of the nucleus from the SA4 complex being a 
rate-limiting step), removing capping would likely destabilize the 
SA4 structure and could favor nucleation.
How do tandem-WH2-domain nucleators bind filament pointed 
ends? Single-molecule observations showed that VopL/F remains 
associated with the pointed ends of filaments it nucleates for ∼100 
s (Burke et al., 2017). In the absence of actin monomers, VopL/F 
binds pointed ends for shorter times (∼25 s). Higher affinity bind-
ing is likely due to the contribution of the VopL/F C-terminal do-
main, which dimerizes and binds the pointed end. In the case of 
Spir, weak inhibition of depolymerization may be mediated by a 
linker or a domain straddling the WH2 domains. Side binding by 
the C-terminal half of tandem WH2 domains may enhance rela-
tively weak pointed-end binding of both Spir and VopL/F. Side 
binding by Spir is consistent with the fact that it can sever filaments 
(Bosch et al., 2007; Chen et al., 2012). The resolution of our bead 
assay is not sufficient to distinguish between direct binding to the 
pointed end and binding to the filament side near the pointed 
end. Additionally, pointed-end elongation is difficult to detect with 
low actin concentrations and is essentially nonexistent in the pres-
ence of profilin. Thus, we speculate that the ability to retain the 
pointed ends of filaments nucleated by Spir on beads reflects en-
hanced binding, perhaps to both filament sides and the pointed 
end, due to clustering on beads (Figure 8A). Multiple cases of 
emergent behavior of clustered WH2 domains have been re-
ported. Spir nucleates more potently when clustered on gold par-
ticles (Ito et al., 2011). VopL retains the pointed end of ∼10% of 
nucleated filaments for several minutes (compared with seconds 
for ∼80% of filaments) and accelerates barbed-end elongation of 
∼8% of filaments when clustered on Qdots (Namgoong et al., 
2011); and Ena/VASP are potent elongation factors when clustered 
on beads (Breitsprecher et al., 2008; Winkelman et al., 2014). In 
sum, WH2 domains can associate with both ends of actin filaments 
and they are likely to function as part of a larger context that 
dictates their activity (Dominguez, 2016).
How do Spir and Capu synergize?
Synergy of actin assembly can be explained by enhanced nucleation 
and/or elongation. In the cases of Bud6/Bni1 and APC/mDia1, 
nucleation is enhanced (Graziano et al., 2011; Breitsprecher et al., 
2012). We propose that increased nucleation is also the dominant 
source of synergy for Spir/Capu. The ping-pong model suggests 
that Spir and Capu (Fmn2) enhance elongation by dynamic ex-
change at the barbed ends of filaments. A key element of the ping-
pong model is that Fmn2 binds barbed ends with a slow on-rate. 
Thus, by recruiting Fmn2 to barbed ends, Spir increases the fraction 
of time that elongation is enhanced by the formin. We found that 
synergistic assembly of profilin–actin is actually improved in the 
absence of Spir binding to barbed ends (CapuCT+SpirNT(A*)). We 
also directly observed increased nucleation in bead assays: 
CapuCT/SpirNT-beads nucleate 6× and 10× more potently than 
SpirNT-beads, with or without a functional WH2-A, respectively 
(Figures 5D and 6, C–E). A full comparison (i.e., nucleation by 
SpirNT-beads and CapuCT-beads, vs. CapuCT/SpirNT-beads) was 
precluded by the inactivity of CapuCT-beads, regardless of the 
coupling method. Finally, we see a fourfold increase in nucleation 
by CapuCT/SpirNT(A*)-beads compared with wild-type CapuCT/
SpirNT-beads, similar to the approximately three times decrease in 
t1/2 in bulk pyrene assays (Figure 6B). Thus, we conclude that 
nucleation is the major source of enhanced actin assembly medi-
ated by Spir/Capu synergy.
Ping-ponging may still take place and contribute to mesh assem-
bly. We observe transfer of Capu-bound barbed ends to Spir (Figure 
4C and Supplemental Video 8), consistent with one half of ping-
pong. We do not see transfer in the other direction, but our bead-
based assay is not well suited to studying this process, as we do not 
have excess Spir or Capu in solution. (The original observation of 
ping-pong was made with all proteins in solution [Montaville et al., 
2014].) Importantly, the intermediate phenotype we observe in flies 
expressing Spir(A*)-GFP (Figure 7, D and D′, and Table 1) could 
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FIGURE 8: Model of Spir–Capu synergy. (A) Spir is directed to vesicles through its phospholipid-
binding mFYVE domain (green helix). The clustering of Spir on vesicles may enhance its affinity 
for filament pointed ends. Each of Spir’s tandem, WH2 domains (light blue) can bind to an actin 
subunit (dark-gray spheres). (B) Spir and Capu interact through their respective KIND (purple) 
and tail (yellow) domains. (B′) Spir retains a filament’s pointed end (dark gray), while Capu 
separates from Spir to elongate its barbed end (light gray). (C) A filament’s barbed end is 
captured and capped by Spir’s WH2-A domain (light blue), displacing Capu. Spir’s bipolar 
filament binding may tether vesicles, as shown. (C′) Associated with Rab11 (pink) and Spir on 
vesicles, MyoV (dark blue) may tow a nucleating vesicle (left) toward another, receiving (filament 
capturing) vesicle (right).
indicate that, while not necessary, ping-ponging may enhance mesh 
assembly in the oocyte. Perhaps Spir helps Capu fall off of filaments 
when they reach their target. Additionally, Spir could pass the 
filament to another protein that anchors it at the vesicle even more 
stably, influencing the dynamics of the mesh. It is also possible that 
capping serves an important role in vivo, independent of the 
processes we are studying here.
The classical nucleation promoting factors (NPFs), N-Wasp and 
Scar, bind actin monomers and the Arp2/3 complex to stimulate 
nucleation by the Arp2/3 complex (Machesky et al., 1999; Welch 
and Mullins, 2002). Similarly, the yeast NPF, Bud6, binds an actin 
monomer and the formin Bni1 to stimulate nucleation by Bni1 
(Graziano et al., 2011; Tu et al., 2012; Park et al., 2015). In each of 
these cases, the NPF has negligible independent activity. In con-
trast, APC and Spir can nucleate alone, as well as synergize with a 
formin (Quinlan et al., 2005; Moseley et al., 2007; Okada et al., 
2010; Montaville et al., 2014). We note that Spir’s nucleation 
activity in the presence of profilin corre-
lates with synergy: in the absence of nucle-
ation by SpirNT(A*B*C*D*), no synergy is 
observed; when nucleation is augmented 
(SpirNT(A*) nucleation is approximately 
three times stronger than SpirNT), synergy 
with Capu is also enhanced over wild type 
(approximately four times). These are only 
two data points, but they suggest that 
Spir’s nucleation contributes to synergy, as 
opposed to Spir acting as a passive actin-
binding protein, or NPF. In fact, if monomer 
delivery were Spir’s main role, one might 
expect SpirNT(A*) to be a weaker Capu ac-
tivator because it has fewer functional WH2 
domains. Thus, we propose that Spir and 
Capu collaborate by a mechanism similar 
to that of APC/mDia1; Spir nucleates seeds 
that are elongated by Capu (Figure 8B).
In vivo implications
The filament orientation we observe 
(barbed ends away from the bead) reflects 
the fact that Spir is attached to the beads 
and Capu is bound to Spir in our assays. As 
we and others have shown, when a formin 
is bound to a bead, filaments grow with 
their barbed ends at the bead surface. 
Both mSpire and Fmn-2 are enriched on 
Rab-11 vesicles. We speculate that Fmn2 is 
affiliated by binding mSpire as opposed to 
an independent association with the vesi-
cle. We base this on the finding that mSpire 
binds directly to membranes and the fact 
that, in flies, GFP-Capu is diffuse through-
out the oocyte (Quinlan, 2013; Tittel et al., 
2015). If we are correct, then the geometry 
in our assays mimics the in vivo geometry 
and indicates that the actin filaments 
are oriented opposite to what was origi-
nally proposed by others (Schuh, 2011; 
Montaville et al., 2014). Long distance 
transport is still possible with this orienta-
tion of filaments (Figure 8C). Instead of 
myosin V capturing filaments from a neigh-
boring vesicle, Spir or another protein could capture a growing 
filament, and myosin V, on the vesicle from which the filament 
originated, could walk along the filament pulling the vesicle to-
ward its neighbor (Figure 8C′). In this case, pointed-end attach-
ment would not have to be as long lasting as barbed-end capture. 
These conditions are surprisingly well satisfied in our simplified 
system.
Increased Capu expression is sufficient to build a mesh in the 
absence of Spir or in the absence of direct interaction with Spir 
(Dahlgaard et al., 2007; Quinlan, 2013). In these cases, the mesh is 
not as dense or as long lived. No mesh is built when exogenous 
Spir expression is driven in the absence of Capu (Dahlgaard et al., 
2007). Thus, we propose that Spir’s primary role in vivo is as an 
NPF, enhancing Capu’s actin assembly activity. NPFs offer an 
additional level of control in the cell and may relieve the nucle-
ation-dampening effect of profilin on formins like Capu. In the case 
of the fly oocyte, we also note that the cytoplasm is enriched with 
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microtubules that potently inhibit Capu by binding to its tail, 
where the Spir-KIND domain also binds (Roth-Johnson et al., 
2014). Thus, Spir is well suited to simultaneously protect Capu 
from inhibitory factors and amplify its activity. The fact that Spir(A*)-
GFP expression largely rescues loss of Spir indicates that barbed-
end binding by Spir is not necessary for oogenesis. We note, 
however, that actin nucleation by SpirNT(A*) alone and with Capu 
is enhanced, which could compensate for loss of ping-ponging or 
other barbed-end binding roles of Spir.
MATERIALS AND METHODS
DNA constructs
CapuCT (aa 467–1059) constructs were expressed from a modified 
pET15b vector with an N-terminal hexahistidine tag (Vizcarra et al., 
2011). All other proteins were expressed from a modified pET20b(+) 
vector with no affinity tag. A native polyhistidine region within the 
Spir-KIND domain is sufficient for binding of these constructs to 
TALON resin (Clontech).
Gibson cloning was employed for the scar-free introduction of 
Avidity’s 45 base pair Avitag (translated sequence: GLN-
DIFEAQKIEWHE) to all proteins requiring biotinylation for bead 
conjugation. This tag was introduced to the C-terminus of all 
constructs.
Expression, purification, and biotinylation of proteins
Actin was purified from Acanthamoeba castellani as described 
(Zuchero, 2007) and stored in G-buffer (2 mM Tris-Cl, pH 8.0, 
0.1 mM CaCl2, 0.2 mM ATP, 0.5 mM Tris(2-carboxyethyl)phosphine 
[TCEP], 0.04% sodium azide).
Expression was induced in Rosetta (DE3) cells (EMD Biosciences). 
Bacteria were grown in Terrific Broth medium supplemented with 
100 mg/l ampicillin and 32 mg/l chloramphenicol. Cells were grown 
to an optical density of 0.6 at 37°C, cooled to 18°C for 1 h, induced 
with 250 μM isopropyl β-d-1-thiogalactopyranoside (IPTG), and 
shaken for 18 h at 18°C. Bacteria were harvested by centrifugation. 
Pellets were washed once with ice-cold phosphate-buffered saline 
(PBS), flash-frozen in liquid nitrogen, and stored at −80°C.
All purification steps were carried out at 4°C or on ice. Thawed 
cells were diluted at least twofold with lysis buffer (50 mM sodium 
phosphate, pH 8.0, 1 mM β-ME, 300 mM NaCl) supplemented 
with 1 mM phenylmethylsulfonyl fluoride and 2 μg∕ml DNaseI, and 
then lysed by microfluidizing, two to three times. Cell debris was 
removed by centrifugation at 20,000 × g for 20 min at 4°C. Clari-
fied lysates were then rocked with TALON resin for 1 h at 4°C (4 ml 
slurry for every 1 l culture pellet). The TALON resin was washed 
with 20 column volumes of lysis buffer, followed by washing with 
20 column volumes of wash buffer (lysis buffer, at pH 7.0). Proteins 
were eluted with elution buffer (wash buffer, plus 200 mM imidaz-
ole), until little or no protein remained on the column, as deter-
mined by a Coomassie-stained dot-blot of the eluates.
TALON eluates were pooled and dialyzed twice for 2 h and 
once overnight against 1 l volumes of 10 mM Tris, 1 mM dithio-
threitol (DTT), pH 8.0; or 5 ml of the most concentrated eluates 
was buffer exchanged into the same, using a PD-10 desalting col-
umn (GE Life Sciences). Protein was loaded onto a MonoQ anion 
exchange column (GE Life Sciences) and eluted using a gradient 
of 50–500 mM KCl over 60 column volumes for Spir-KIND, 50–250 
mM KCl over 100 column volumes for CapuCT, or 0–500 mM KCl 
over 60 column volumes for SpirNT. Pooled fractions from the 
MonoQ column were again dialyzed or buffer exchanged as de-
scribed above. Unless tagged with an Avitag, 50% glycerol was 
added to the overnight dialysis step (1:1 glycerol:buffer). The pro-
tein was flash-frozen in liquid nitrogen in 10–50 μl aliquots and 
stored at −80°C.
If tagged with an Avitag, 2 ml of the protein was added to 223 μl 
Biomix B and 5 μl (5 μg) BirA (both from Avidity) and rocked over-
night at 4°C. The reaction was again loaded onto a MonoQ anion 
exchange column and eluted as described above. Pooled fractions 
from the MonoQ column were dialyzed or buffer exchanged as de-
scribed above, with 50% glycerol added to the overnight dialysis 
step and flash-frozen in liquid nitrogen.
Spir-KIND, SpirNT, and CapuCT concentrations were calculated 
based on their absorbances at 280 nm (ε280 = 17,452 cm−1 M−1 for 
KIND, 25,575 cm−1 M−1 for Spir-NT, and 75,200 cm−1 M−1 for Capu-
CT; Quinlan et al., 2007).
Purified, SNAP-tagged mDia1 protein was generously provided 
by the Kovar lab (University of Chicago).
Pyrene-actin assembly assays
Bulk actin assembly assays were carried out essentially as described 
(Zuchero, 2007). Briefly, actin (5% pyrene labeled) was incubated for 
2 min at 25°C with 200 μM ethylene glycol-bis(β-aminoethyl ether)-
N,N,N′,N′-tetraacetic acid (EGTA) and 50 μM MgCl2 to convert Ca-
actin to Mg-actin. When included in the experiment, Schizosaccharo-
myces pombe profilin (typically 2:1 profilin:actin) was incubated with 
actin for 2 min at 25°C before conversion to Mg-actin. Polymerization 
was initiated by adding polymerization buffer (“KMEH,” final con-
centration: 10 mM HEPES, pH 7.0, 1 mM EGTA, 50 mM KCl, 1 mM 
MgCl2) to the Mg-actin. Additional components, such as CapuCT, 
SpirNT, and capping protein, were combined in the polymerization 
buffer before addition to Mg-actin. Fluorescence was monitored in a 
TECAN F200 with λex = 360 ± 17 nm and λem = 400 ± 10 nm.
Actin seeds were prepared by polymerizing 5 μM actin at 25°C 
for 1 h in KMEH. The filaments were dispensed in 5 μl aliquots and 
allowed to reequilibrate for 2–3 h at 25°C. SpirNT was incubated 
with filaments for 3 min at 25°C. During this incubation time, mono-
meric actin was converted to Mg-actin. Using a cut pipette tip to 
prevent shearing, polymerization buffer was added to Mg-actin 
and then mixed with seeds plus SpirNT. The slope of the pyrene 
fluorescence trace between 200 and 500 s was considered the 
elongation rate.
SpirNT-bead preparation
Streptavidin-coated microspheres were either colorless or Flash Red 
fluorescent, with mean diameters of ∼100 nm or ∼1 μm (Bangs 
Laboratories), respectively. Spheres were washed twice with ∼20 
volumes of KMEH, resuspended in 1 volume of KMEH + 1 mg/ml 
bovine serum albumin, and added in 10 μl aliquots to 40 μl protein 
mixtures in KMEH. The protein mixture always included a saturating 
concentration of SpirNT-biotin (400 nM). When included, 200 nM 
(dimeric) CapuCT was preincubated with the SpirNT-biotin on ice for 
10 min to allow the formation of SpirNT–CapuCT complexes. 
Protein mixtures were incubated with spheres for 10 min on ice and 
then spun for 10 min at 10,000× rpm and 4°C. Buffer and excess 
proteins (i.e., unbound SpirNT–biotin and CapuCT) were aspirated 
and pellets were gently resuspended in 30 μl KMEH. Pellets were 
briefly sonicated (∼5 s) if clumped and not well dispersed when 
visualized by TIRF microscopy.
TIRF microscopy assays
Coverslips were prepared and functionalized with polyethylene 
glycol (final surface composition, 97% methoxy-PEG and 3% biotin-
PEG; JenKem Technology, Allen, TX) as previously described 
(Bor et al., 2012). Biotinylated coverslips were stored in a sealed 
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container at 4°C for up to 2 mo before use. Flow cells with volumes 
of ∼10–15 μl were assembled using thin strips of double-stick tape.
All buffers were flowed into cells in 25 μl volumes in the following 
order: 1) blocking buffer (1X PBS, pH 8.0, 1% pluronic, 0.1 mg/ml 
casein) with 2 min incubation; 2) TIRF buffer (50 mM KCl, 1 mM 
MgCl2, 1 mM EGTA, 10 mM HEPES, pH 7.0, 0.2 mM ATP, 50 mM 
DTT, 0.2% methylcellulose, 20 mM glucose); 3) prepared beads (5 μl 
resuspended beads, 25 μl TIRF buffer) with 2 min incubation; 4) TIRF 
buffer; 5) TIRF buffer, supplemented with GCC mix (0.25 mg/ml glu-
cose oxidase, 0.05 mg/ml catalase, 0.8 mg/ml casein), actin (typically 
1 μM, 20% Oregon Green labeled), and profilin and/or capping pro-
tein, when appropriate. In this final step, actin and profilin (when pres-
ent) were mixed and incubated for 1 min, then added to the other 
buffer components immediately before being flowed into the cell.
Time zero was defined as the moment the final 25 μl mix, 
including actin, was entirely added. Polymerization was visualized 
immediately (typically, t = ∼30 s) on a DMI6000B TIRF microscope 
(Leica, Wetzlar, Germany), controlled by LAS X (Leica software). 
Images were acquired with a DU897 EMCCD camera (Andor) and 
100×/1.47 HCX PL APO objective (Leica) at ∼25°C. All analyses were 
performed on raw data in FIJI. The brightness and contrast of figure 
images were minimally adjusted for clarity of image features. 
Filament lengths, elongation rates, and kymographs were analyzed/
prepared with JFilament incorporated in FIJI (Smith et al., 2010). 
Plots were made and statistical analyses conducted in Kaleidagraph. 
Filament dwell times were obtained by manually tracking individual, 
retained filaments until clearly released from a bead. Some filaments 
did not become clearly visible in the TIRF plane until some growth 
had already occurred. In these cases, time was added to the 
measured retention period, proportional to the initial length of 
the filament and the average filament elongation rate observed in 
the experiment.
For two-color experiments, 1 μM Cy3B-labeled actin was intro-
duced to the functionalized, bead-bound flow cell. Following this 
(step 5 of the aforementioned protocol), and after allowing beads to 
briefly (1–2 mins) polymerize the Cy3B-actin, the following compo-
nents were flowed in: 6) TIRF buffer supplemented with 1 μM 
phalloidin, with 2 min incubation; 7) TIRF buffer supplemented with 
GCC mix, 600 nM 20% labeled OG-actin, and 300 nM profilin. 
Polymerization was visualized as described above.
For the plots generated in Figure 6, D and E, circles of 10 and 
11 pixel (px) radii (1.6 and 1.76 μm, respectively) were drawn around 
the centroids of each bead. Actin fluorescence was measured within 
these circles over time. The integrated density measurements of the 
10 px circles were subtracted from those of their concentric, 11 px 
circles, to measure 1-px-wide (160 nm) bands of actin fluorescence, 
1.6 μm away from beads. A script that performs these operations in 
FIJI is available upon request.
Fluorescence measurements in Figure 6, D and E, are expressed 
as a fraction of their initial values (i.e., a 10% increase = 1.1). Discrep-
ancies in initial fluorescence values for different bead types were 
observed, in part, due to real differences in assembly rates, because 
actin polymerization could not be observed instantly. To scale these 
differences in assembly before image collection, the average start-
ing values of each bead type were compared. The larger ratio of 
these two values was used as a multiplier for the more active bead 
type. For example, if measurements of SpirNT(A*)- and SpirNT-
beads were 110% their initial values, these quantities would each be 
plotted as “1.1.” However, if the average, initial values of SpirNT(A*)-
beads were twice those of SpirNT-beads, the quantities would be 
plotted as “2.2” and “1.1,” respectively, reflecting the twofold 
greater assembly by SpirNT(A*)-beads before image collection.
Drosophila stocks
The following stocks were obtained from the Bloomington 
Drosophila Stock Center: spir1 and capu1 (Manseau and 
Schüpbach, 1989); Df(2L)Exel6046 (Exelixis); and nos-GAL4-vp16 
(Van Doren et al., 1998). Mutant SpirB-GFP transgenes were 
generated by inserting the coding region of spir (CG10076-RB) 
with point mutations created by QuikChange mutagenesis, 
between the KpnI and SpeI sites of pTIGER (Ferguson et al., 
2012) with mEGFP inserted between the BamHI and XbaI sites. 
pTIGER plasmids were integrated at the attP2 landing site by 
BestGene.
Fertility assays
Approximately 100 test females were crossed to 40 wild-type males 
and kept on apple plates for two nights at 25°C. Flies were pre-
cleared on a fresh plate with yeast paste for at least 1.5 h; the plate 
was changed and eggs laid over the next 3 h were collected. Typi-
cally, 100 eggs were laid in this time period. Eggs were transferred 
to a fresh plate and stored at 25°C. The number of eggs that hatched 
after 24 h was recorded. Each trial was repeated at least three times 
with independent crosses.
Fly oocyte microscopy and staining
The visualization of cytoplasmic flows and the actin mesh were per-
formed on a Leica SPE I inverted confocal microscope. Flies were 
kept at 25°C and fed yeast paste for ∼24 h before an experiment. 
Flows were visualized by imaging autofluorescent yolk granules of 
egg chambers teased apart in Halocarbon oil 700. The actin mesh 
was stained as described by Dahlgaard et al. (2007) with modifica-
tions. Briefly, ovaries were dissected, teased apart, and fixed in 10% 
paraformaldehyde/PBS (pH 7.4) for a total of less than 20 min. Sam-
ples were stained with 1 μM Alexa Fluor 488–phalloidin diluted in 
0.3% Triton X-100/PBS for 25 min at room temperature. Samples 
were then washed extensively and mounted in ProLong Gold with 
4′,6-diamidino-2-phenylindole (DAPI). Images were recorded within 
24 h of staining because phalloidin staining quality degraded over 
time, as has been reported (Dahlgaard et al., 2007).
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